CONFERENCEDetailed view
To promote the implementation of new screening approaches, EUCanScreen is working closely with the TOGAS project. This collaboration enables the exchange of knowledge and resources, improving the overall impact on cancer prevention and early diagnosis in Europe. The TOGAS project aims to develop recommendations for the implementation of gastric cancer screening in EU countries through three large-scale pilot studies. The project is developing various aspects of early diagnosis of gastric cancer, although one of the major challenges is the development of guidelines that comply with medical ethics standards. In order to ensure effective data sharing and develop common guidelines for gastric cancer prevention, both TOGAS and EUCanScreen are working closely with the EUROHELICAN project, which evaluates a population-based strategy for testing and eradicating Helicobacter pylori. The project has achieved significant progress, but challenges lie in assessing the potential negative long-term effects of the strategy.
The JANE-2 project plays a significant role in improving the quality of life, both in the fight against cancer and after the disease has been overcome. The project aims to develop seven new, interconnected networks of expertise, accessible to both patients and healthcare professionals. Currently, the project's main challenge is ensuring effective information flow and coordination between different expert groups. To promote a multidisciplinary approach to cancer treatment and prevention, JANE-2 intends to collaborate with EUnetCCC and EUCanScreen.
It is also worth mentioning the Echos project, as it is working on the establishment of national cancer mission centers, while CCI4EU is focused on strengthening capacity for comprehensive cancer center infrastructure in all European Union member states and several associated countries.
The meeting highlighted future perspectives, such as using artificial intelligence solutions for cancer screening. New solutions are being sought to improve early detection of malignancy and more accurately identify which patients are at the highest risk. One of the most advanced approaches is to use artificial intelligence to analyze large amounts of data to predict and diagnose diseases in their early stages. A key component of the AIDA project is its focus on Helicobacter pylori. The project is developing a comprehensive European Helicobacter pylori patient registry to collect data on patients with this infection and their gastric health status. By combining this data with the results of endoscopies and biopsies, the AIDA artificial intelligence system will learn to recognize early, precancerous changes in the stomach. As a result, such a system could improve patient care by providing doctors with an additional tool to help them decide which patients require closer monitoring, additional examinations, or preventive treatment.
A common communication strategy to ensure the more effective dissemination of information and public education on cancer prevention, as well as closer cooperation with other European projects and organizations, was also identified as an important direction for future development.
The synergy event of the Institute of Clinical and Preventive Medicine of the University of Latvia projects demonstrated that collaboration and synergy between different projects is key to effective cancer prevention and treatment. Participants confirmed their commitment to continue working on the implementation of innovative solutions and the development of sustainable screening programmes, thus contributing to a healthier and safer future across Europe. This exchange of experience and knowledge not only contributes to more efficient implementation of projects but also provides hope for significant progress in the fight against cancer.
